| JXQ | Name: | 9-hex-5-ynylpurin-6-amine | Formula: | C11 H13 N5 | SMILES: | Nc1ncnc2n(CCCCC#C)cnc12 | InChi: | InChI=1S/C11H13N5/c1-2-3-4-5-6-16-8-15-9-10(12)13-7-14-11(9)16/h1,7-8H,3-6H2,(H2,12,13,14) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-hex-5-ynylpurin-6-amine |
|
| JXT | Name: | 8-bromanyl-9-pent-4-ynyl-purin-6-amine | Formula: | C10 H10 Br N5 | SMILES: | Nc1ncnc2n(CCCC#C)c(Br)nc12 | InChi: | InChI=1S/C10H10BrN5/c1-2-3-4-5-16-9-7(15-10(16)11)8(12)13-6-14-9/h1,6H,3-5H2,(H2,12,13,14) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 8-bromanyl-9-pent-4-ynyl-purin-6-amine |
|
| JXW | Name: | 9-(2-chloroethyl)-8-methyl-purin-6-amine | Formula: | C8 H10 Cl N5 | SMILES: | Cc1nc2c(N)ncnc2n1CCCl | InChi: | InChI=1S/C8H10ClN5/c1-5-13-6-7(10)11-4-12-8(6)14(5)3-2-9/h4H,2-3H2,1H3,(H2,10,11,12) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-(2-chloroethyl)-8-methyl-purin-6-amine |
|
| Q2D | Name: | 3-{[(3R)-3-({6-amino-8-[(6-iodo-2H-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}methyl)piperidin-1-yl]methyl}benzene-1-sulfonyl fluoride | Formula: | C25 H24 F I N6 O4 S2 | SMILES: | c12ncnc(c1nc(n2CC3CN(CCC3)Cc4cccc(c4)S(F)(=O)=O)Sc6c(cc5c(OCO5)c6)I)N | InChi: | InChI=1S/C25H24FIN6O4S2/c26-39(34,35)17-5-1-3-15(7-17)10-32-6-2-4-16(11-32)12-33-24-22(23(28)29-13-30-24)31-25(33)38-21-9-20-19(8-18(21)27)36-14-37-20/h1,3,5,7-9,13,16H,2,4,6,10-12,14H2,(H2,28,29,30)/t16-/m1/s1 | Definition date: | 2019-09-10 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 3-{[(3R)-3-({6-amino-8-[(6-iodo-2H-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}methyl)piperidin-1-yl]methyl}benzene-1-sulfonyl fluoride |
|
| JXZ | Name: | 2-(6-azanyl-8-methyl-purin-9-yl)ethanol | Formula: | C8 H11 N5 O | SMILES: | Cc1nc2c(N)ncnc2n1CCO | InChi: | InChI=1S/C8H11N5O/c1-5-12-6-7(9)10-4-11-8(6)13(5)2-3-14/h4,14H,2-3H2,1H3,(H2,9,10,11) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 2-(6-azanyl-8-methyl-purin-9-yl)ethanol |
|
| JY2 | Name: | 8-methyl-9-pent-4-ynyl-purin-6-amine | Formula: | C11 H13 N5 | SMILES: | Cc1nc2c(N)ncnc2n1CCCC#C | InChi: | InChI=1S/C11H13N5/c1-3-4-5-6-16-8(2)15-9-10(12)13-7-14-11(9)16/h1,7H,4-6H2,2H3,(H2,12,13,14) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 8-methyl-9-pent-4-ynyl-purin-6-amine |
|
| JY5 | Name: | 3-[6-azanyl-9-[(2~{R})-oxan-2-yl]purin-8-yl]prop-2-yn-1-ol | Formula: | C13 H15 N5 O2 | SMILES: | Nc1ncnc2n([CH]3CCCCO3)c(nc12)C#CCO | InChi: | InChI=1S/C13H15N5O2/c14-12-11-13(16-8-15-12)18(9(17-11)4-3-6-19)10-5-1-2-7-20-10/h8,10,19H,1-2,5-7H2,(H2,14,15,16)/t10-/m1/s1 | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 3-[6-azanyl-9-[(2~{R})-oxan-2-yl]purin-8-yl]prop-2-yn-1-ol |
|
| JY8 | Name: | 9-ethyl-8-methyl-purin-6-amine | Formula: | C8 H11 N5 | SMILES: | CCn1c(C)nc2c(N)ncnc12 | InChi: | InChI=1S/C8H11N5/c1-3-13-5(2)12-6-7(9)10-4-11-8(6)13/h4H,3H2,1-2H3,(H2,9,10,11) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-ethyl-8-methyl-purin-6-amine |
|
| JYB | Name: | 9-ethyl-8-ethynyl-purin-6-amine | Formula: | C9 H9 N5 | SMILES: | CCn1c(nc2c(N)ncnc12)C#C | InChi: | InChI=1S/C9H9N5/c1-3-6-13-7-8(10)11-5-12-9(7)14(6)4-2/h1,5H,4H2,2H3,(H2,10,11,12) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-ethyl-8-ethynyl-purin-6-amine |
|
| JYE | Name: | 9-(3-azidopropyl)-8-bromanyl-purin-6-amine | Formula: | C8 H9 Br N8 | SMILES: | Nc1ncnc2n(CCCN=[N+]=[N-])c(Br)nc12 | InChi: | InChI=1S/C8H9BrN8/c9-8-15-5-6(10)12-4-13-7(5)17(8)3-1-2-14-16-11/h4H,1-3H2,(H2,10,12,13) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-(3-azidopropyl)-8-bromanyl-purin-6-amine |
|
| JYN | Name: | 9-(4-azidobutyl)purin-6-amine | Formula: | C9 H12 N8 | SMILES: | Nc1ncnc2n(CCCCN=[N+]=[N-])cnc12 | InChi: | InChI=1S/C9H12N8/c10-8-7-9(13-5-12-8)17(6-14-7)4-2-1-3-15-16-11/h5-6H,1-4H2,(H2,10,12,13) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-(4-azidobutyl)purin-6-amine |
|
| JYQ | Name: | ~{S}-[4-(6-aminopurin-9-yl)butyl] ethanethioate | Formula: | C11 H15 N5 O S | SMILES: | CC(=O)SCCCCn1cnc2c(N)ncnc12 | InChi: | InChI=1S/C11H15N5OS/c1-8(17)18-5-3-2-4-16-7-15-9-10(12)13-6-14-11(9)16/h6-7H,2-5H2,1H3,(H2,12,13,14) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | ~{S}-[4-(6-aminopurin-9-yl)butyl] ethanethioate |
|
| JYT | Name: | 3-(6-azanyl-8-bromanyl-purin-9-yl)propan-1-ol | Formula: | C8 H10 Br N5 O | SMILES: | Nc1ncnc2n(CCCO)c(Br)nc12 | InChi: | InChI=1S/C8H10BrN5O/c9-8-13-5-6(10)11-4-12-7(5)14(8)2-1-3-15/h4,15H,1-3H2,(H2,10,11,12) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 3-(6-azanyl-8-bromanyl-purin-9-yl)propan-1-ol |
|
| JYW | Name: | 4-(6-azanyl-8-bromanyl-purin-9-yl)butan-1-ol | Formula: | C9 H12 Br N5 O | SMILES: | Nc1ncnc2n(CCCCO)c(Br)nc12 | InChi: | InChI=1S/C9H12BrN5O/c10-9-14-6-7(11)12-5-13-8(6)15(9)3-1-2-4-16/h5,16H,1-4H2,(H2,11,12,13) | Definition date: | 2019-04-11 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 4-(6-azanyl-8-bromanyl-purin-9-yl)butan-1-ol |
|
| J6B | Name: | ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{R})-6-azanyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-3-fluoranyl-4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Formula: | C27 H37 F N6 O4 S | SMILES: | CC(C)C[CH](NC(=O)c1ccc(c(F)c1)c2csc(n2)N3CCN(C)CC3)C(=O)N4C[CH](N)[CH]5OC[CH](O)[CH]45 | InChi: | InChI=1S/C27H37FN6O4S/c1-15(2)10-20(26(37)34-12-19(29)24-23(34)22(35)13-38-24)30-25(36)16-4-5-17(18(28)11-16)21-14-39-27(31-21)33-8-6-32(3)7-9-33/h4-5,11,14-15,19-20,22-24,35H,6-10,12-13,29H2,1-3H3,(H,30,36)/t19-,20+,22+,23-,24-/m1/s1 | Definition date: | 2019-02-01 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{R})-6-azanyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-3-fluoranyl-4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide |
|
| KF5 | Name: | 9-[(2~{S})-oxan-2-yl]purin-6-amine | Formula: | C10 H13 N5 O | SMILES: | Nc1ncnc2n(cnc12)[CH]3CCCCO3 | InChi: | InChI=1S/C10H13N5O/c11-9-8-10(13-5-12-9)15(6-14-8)7-3-1-2-4-16-7/h5-7H,1-4H2,(H2,11,12,13)/t7-/m0/s1 | Definition date: | 2019-05-17 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | 9-[(2~{S})-oxan-2-yl]purin-6-amine |
|
| K0Q | Name: | ~{N}-[2-(1~{H}-indol-3-yl)ethyl]-2-(3-oxidanyl-2-oxidanylidene-pyridin-1-yl)ethanamide | Formula: | C17 H17 N3 O3 | SMILES: | OC1=CC=CN(CC(=O)NCCc2c[nH]c3ccccc23)C1=O | InChi: | InChI=1S/C17H17N3O3/c21-15-6-3-9-20(17(15)23)11-16(22)18-8-7-12-10-19-14-5-2-1-4-13(12)14/h1-6,9-10,19,21H,7-8,11H2,(H,18,22) | Definition date: | 2019-04-12 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | ~{N}-[2-(1~{H}-indol-3-yl)ethyl]-2-(3-oxidanyl-2-oxidanylidene-pyridin-1-yl)ethanamide |
|
| KUQ | Name: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-phenyl-1~{H}-imidazol-4-yl)oxane-3,4,5-triol | Formula: | C15 H18 N2 O5 | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)c2c[nH]c(n2)c3ccccc3 | InChi: | InChI=1S/C15H18N2O5/c18-7-10-11(19)12(20)13(21)14(22-10)9-6-16-15(17-9)8-4-2-1-3-5-8/h1-6,10-14,18-21H,7H2,(H,16,17)/t10-,11-,12+,13-,14+/m1/s1 | Definition date: | 2019-06-28 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-phenyl-1~{H}-imidazol-4-yl)oxane-3,4,5-triol |
|
| KV5 | Name: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-naphthalen-2-yl-1~{H}-imidazol-4-yl)oxane-3,4,5-triol | Formula: | C19 H20 N2 O5 | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)c2c[nH]c(n2)c3ccc4ccccc4c3 | InChi: | InChI=1S/C19H20N2O5/c22-9-14-15(23)16(24)17(25)18(26-14)13-8-20-19(21-13)12-6-5-10-3-1-2-4-11(10)7-12/h1-8,14-18,22-25H,9H2,(H,20,21)/t14-,15-,16+,17-,18+/m1/s1 | Definition date: | 2019-06-29 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-naphthalen-2-yl-1~{H}-imidazol-4-yl)oxane-3,4,5-triol |
|
| KVE | Name: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-(4-naphthalen-2-yl-1,3-thiazol-2-yl)oxane-3,4,5-triol | Formula: | C19 H19 N O5 S | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)c2scc(n2)c3ccc4ccccc4c3 | InChi: | InChI=1S/C19H19NO5S/c21-8-14-15(22)16(23)17(24)18(25-14)19-20-13(9-26-19)12-6-5-10-3-1-2-4-11(10)7-12/h1-7,9,14-18,21-24H,8H2/t14-,15-,16+,17-,18-/m1/s1 | Definition date: | 2019-06-29 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-(4-naphthalen-2-yl-1,3-thiazol-2-yl)oxane-3,4,5-triol |
|
| KVH | Name: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-naphthalen-2-yl-1,3-thiazol-4-yl)oxane-3,4,5-triol | Formula: | C19 H19 N O5 S | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)c2csc(n2)c3ccc4ccccc4c3 | InChi: | InChI=1S/C19H19NO5S/c21-8-14-15(22)16(23)17(24)18(25-14)13-9-26-19(20-13)12-6-5-10-3-1-2-4-11(10)7-12/h1-7,9,14-18,21-24H,8H2/t14-,15-,16+,17-,18+/m1/s1 | Definition date: | 2019-06-29 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-naphthalen-2-yl-1,3-thiazol-4-yl)oxane-3,4,5-triol |
|
| KVN | Name: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-(5-phenyl-1,2,3,4-tetrazol-2-yl)oxane-3,4,5-triol | Formula: | C13 H16 N4 O5 | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)n2nnc(n2)c3ccccc3 | InChi: | InChI=1S/C13H16N4O5/c18-6-8-9(19)10(20)11(21)13(22-8)17-15-12(14-16-17)7-4-2-1-3-5-7/h1-5,8-11,13,18-21H,6H2/t8-,9-,10+,11-,13-/m1/s1 | Definition date: | 2019-07-01 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-(5-phenyl-1,2,3,4-tetrazol-2-yl)oxane-3,4,5-triol |
|
| KVQ | Name: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-phenyl-1,3-thiazol-4-yl)oxane-3,4,5-triol | Formula: | C15 H17 N O5 S | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)c2csc(n2)c3ccccc3 | InChi: | InChI=1S/C15H17NO5S/c17-6-10-11(18)12(19)13(20)14(21-10)9-7-22-15(16-9)8-4-2-1-3-5-8/h1-5,7,10-14,17-20H,6H2/t10-,11-,12+,13-,14+/m1/s1 | Definition date: | 2019-07-01 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{R},5~{R},6~{S})-2-(hydroxymethyl)-6-(2-phenyl-1,3-thiazol-4-yl)oxane-3,4,5-triol |
|
| KVW | Name: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-(4-phenyl-1,3-thiazol-2-yl)oxane-3,4,5-triol | Formula: | C15 H17 N O5 S | SMILES: | OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)c2scc(n2)c3ccccc3 | InChi: | InChI=1S/C15H17NO5S/c17-6-10-11(18)12(19)13(20)14(21-10)15-16-9(7-22-15)8-4-2-1-3-5-8/h1-5,7,10-14,17-20H,6H2/t10-,11-,12+,13-,14-/m1/s1 | Definition date: | 2019-07-01 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-(4-phenyl-1,3-thiazol-2-yl)oxane-3,4,5-triol |
|
| K2H | Name: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-(6-azanyl-9~{H}-purin-8-yl)prop-2-ynyl-methyl-amino]methyl]oxolane-3,4-diol | Formula: | C19 H21 N11 O3 | SMILES: | CN(CC#Cc1[nH]c2ncnc(N)c2n1)C[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)ncnc45 | InChi: | InChI=1S/C19H21N11O3/c1-29(4-2-3-10-27-11-15(20)22-6-24-17(11)28-10)5-9-13(31)14(32)19(33-9)30-8-26-12-16(21)23-7-25-18(12)30/h6-9,13-14,19,31-32H,4-5H2,1H3,(H2,21,23,25)(H3,20,22,24,27,28)/t9-,13-,14-,19-/m1/s1 | Definition date: | 2019-04-16 | Last modified: | 2020-02-14 | Release date: | 2020-02-19 | Identifier: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-(6-azanyl-9~{H}-purin-8-yl)prop-2-ynyl-methyl-amino]methyl]oxolane-3,4-diol |
|